Ault Milton C III - Jul 30, 2025 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
Director, 10%+ Owner
Signature
/s/ Milton C. Ault, III
Stock symbol
ALZN
Transactions as of
Jul 30, 2025
Transactions value $
-$295,532
Form type
4
Date filed
8/1/2025, 04:30 PM
Previous filing
Jul 31, 2025
Next filing
Aug 25, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
AULT MILTON C III Director, 10%+ Owner 11411 SOUTHERN HIGHLANDS PARKWAY, SUITE 190, LAS VEGAS /s/ Milton C. Ault, III 2025-08-01 0001212502

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALZN Common Stock Conversion of derivative security $232K +100K +265.19% $2.32 138K Jul 30, 2025 By Ault Lending, LLC F1, F2
transaction ALZN Common Stock Sale -$74K -29.4K -21.38% $2.51 108K Jul 30, 2025 By Ault Lending, LLC F2, F3
transaction ALZN Common Stock Sale -$222K -100K -92.37% $2.22 8.26K Jul 31, 2025 By Ault Lending, LLC F2, F4
holding ALZN Common Stock 1.84K Jul 30, 2025 Direct
holding ALZN Common Stock 11.1K Jul 30, 2025 By Ault Life Sciences, Inc. F5
holding ALZN Common Stock 61 Jul 30, 2025 By Ault Life Sciences Fund, LLC F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALZN Series B Convertible Preferred Stock Conversion of derivative security -$232K -232 -13.13% $1,000.00 1.54K Jul 30, 2025 Common Stock 100K $2.32 By Ault Lending, LLC F2, F7, F8
holding ALZN Common Stock Purchase Warrants 13.6K Jul 30, 2025 Common Stock 13.6K $108.00 By Ault Lending, LLC F2
holding ALZN Common Stock Purchase Warrants 8.67K Jul 30, 2025 Common Stock 8.67K $108.00 By Ault Lending, LLC F2
holding ALZN Common Stock Purchase Warrants 1.11K Jul 30, 2025 Common Stock 1.11K $108.00 By Ault Lending, LLC F2
holding ALZN Common Stock Purchase Warrants 12 Jul 30, 2025 Common Stock 12 $4,050.00 By Hyperscale Data, Inc. F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock received upon conversion of Series B convertible preferred stock ("Series B Preferred").
F2 Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Hyperscale Data, Inc. ("HSD"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
F3 The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $2.5122. The range of sales prices on the transaction date was $2.4047 to $2.6367 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
F4 The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $2.2155. The range of sales prices on the transaction date was $2.1628 to $2.2511 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
F5 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
F6 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.
F7 The Conversion Price of the Series B Preferred is subject to adjustment as set forth in that certain of Designation of Preferences, Rights and Limitations of the Series B Convertible Voting Preferred Stock.
F8 The shares of Series B Preferred have no expiration date.
F9 Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by HSD.